Nordhealth As · OSL:NORDH
Nordhealth As — Q3 2021 Earnings Presentation
21 slides from Nordhealth As's earnings presentation, Nov 30, 2021
Slide 1: Q3 2021 Presentation
[X) nordhealth Q3 2021 Presentation November 30, 2021
Slide 2: Today's presenters
Today’s presenters Charles MacBain Valter Pasanen CEO CFO
Slide 3: Our mission
Our mission Empowering healthcare professionals to save time so they can focus on what matters most — delivering great care, great experiences, and growing their business
Slide 4: Nordhealth is the leading Nordic healthcare SaaS company
Nordhealth is the leading Nordic healthcare SaaS company W) Business overview * We develop cloud-based Practice Management Software (PMS) for ‘dic company growing internationally Incubator veterinary, physiotherapy, psychotherapy, occupational and speech therapy clinics and hospitals 49.0% ARR split
Slide 5: Strong revenue and growth model
Strong revenue and growth model tN) Crowsnest + Recurring software license fees + Recruit and onboard new clinics with both new and existing customers in . . current and new countries * Repeating transaction fees * Increase adoption of our full suite of products - SMS + Expand the functionality of o
Slide 6: Company updates
(X) nordhealth fo A Company updates Charles MacBain, CEO
Slide 7: KPIs performing according to plan for Q3 2021
KPIs performing according to plan for Q3 2021 LI UL 92% 109% ARR growth 27% organic ARR growth recurring revenue @3 2021 vs. @3 2020 @3 2021 vs. @3 2020 OO © Koy 110% organic net retention rate +18% organic customer recruitments 3% organic ARR gross churn Q3 2021 vs. Q3 2020 Q3 2021 vs. Q3 2020 Q3 2
Slide 8: Operational update — continued ramp up of the organization for international growth
Operational update — continued ramp up of the organization for international growth oO QOA ooh Hoo oon New hires Onboarding New contracts New customers Hired 31 net new employees in Q3 We are onboarding many new Signed partnership agreement with + First Locations of the US + 13.in supportfimplementa
Slide 9: Financial updates
(X) nordhealth CO OLIAO Financial updates Valter Pasanen, CFO
Slide 10: 109% YoY ARR growth
109% YoY ARR growth w) EURm Q3’20ARR NewsignedARR Net upsell Churn Q3'21ARRexcl. Aquisitions Q3’21ARRincl. acquisitions acquisitions Note: Reported in constant currencies 10
Slide 11: 3% QoQ ARR growth
3% QoQ ARR growth EURm 13.6 _ uk} 0. —— 0.1 —{e8l- Seasonality effects 22.9 + Newsigned ARR lower as sales representatives and customers were on vacation * ARR net retention lower partly due to seasonality effects: - Reduced clinic revenue in the summer impacting revenue share-based contracts - No m
Slide 12: Strong Q3'21 YTD with 90% recurring revenue
Strong Q3’21 YTD with 90% recurring revenue Reported financials (EURm) 729 1%) 35 | 125 8.3 73 22 23 Q3'20 YTD Q3'21YTD HB Adj. revenue Adj. recurring revenue Adj. EBITDA Q3'21 YTD Adj. revenue of EUR 13.82m, up 67% YoY Q3'21 YTD Adj. recurring revenue of EUR 12.50m, up 72% YoY Q3'21 YTD Adj. EBITDA
Slide 13: Solid uptick in Q3 2021 vs. Q3 2020
Solid uptick in Q3 2021 vs. Q@3 2020 Reported financials (EURm) ee 87 5.3 29 2.6 0.4 Q3'20 Q3'21 HB Adj. revenue Adj. recurring revenue EBITDA Q3’21 Adjusted revenue of EUR 5.75m, up 95% YoY Q3'21 Adj. recurring revenue of EUR 5.31m, up 105% YoY Successful talent acquisition activities decreased EBI
Slide 14: Strong cashflow generation
Strong cashflow generation w) EURm Hil Reported income i 13.9 Ml Adjusted EBITDA 130 {Adjusted free cash flow -0.3 -0.4 2018 2019 2020 Q3’21YTD 4
Slide 15: Profit & Loss Statement
Profit & Loss Statement Reported P&L - Group consolidated Unaudited Unaudited Unaudited Unaudited Audited EUR inthousands 321 @3'20 YTD2t TD! FY20 Recurringrevenue 5334 2668 12564 7536 10724 Other revenue 434 396 1333 1295 1960 Totalrevenues 5768 3064 13897 8830 12685 Otheroperatingincome 4 () 24 87
Slide 16: Balance Sheet
Balance Sheet Reported balance sheet jp consolidated Unaudited IEUR inthousands Intangibleassets Deferredtaxassets ° Othercapitalizedlong-term expenses var 34 Goodwill arr 4135 Machinery and Equipment 595 3068 Other shares and similar rights of ownership 191 189 Loan receivables, long-term ° 49 Tota
Slide 17: Cashflow Q3'21
Cashflow Q3’21 Reported cash flow statement — Group ci |EURin thousands 30 Sep'21 |Cashflow from operations Purchase of other investments 2) Net cash flow from investments (89200) Net cash flow from financing 10734 ‘Cash and cash equivalents at the end of the period 26650 Moneymarketfund 46515 NY Ca
Slide 18: Prioritizing growth outside of the Nordics
Prioritizing growth outside of the Nordics 2022 plan: 20-25% organic growth in implemented ARR + acquisitions on top 1 Focus on ramping up and training veterinary team in growth markets such as US, UK and Spain to accelerate ARR growth 2 Limited migrations growth in the Nordics due to focus on rampi
Slide 19: Q4 2021 update
Q4 2021 update Q4 2021 update on 18 March 2022 ‘
Slide 20: Slide 20
Slide 21: Nordhealth
[X) nordhealth